BRAIN Biotech AG (ETR:BNN)
2.670
+0.010 (0.38%)
Oct 16, 2026, 5:37 PM CET
BRAIN Biotech AG Market Cap
BRAIN Biotech AG has a market cap or net worth of €58.33 million as of October 16, 2026. It is the 28,295th most valuable company in the world and the 384th biggest in Germany. Its market cap has increased by 26.54% in one year.
Market Cap
58.33M
Enterprise Value
57.39M
Revenue
46.08M
Global Rank
Country Rank
#384 Germany
PE Ratio
n/a
ChartMarket Cap Chart
Since February 9, 2016, BRAIN Biotech AG's market cap has decreased from 149.34M to 58.33M, a decrease of -60.94%. That is a compound annual growth rate of -8.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 58.33M | 5.95% |
| Dec 30, 2025 | 55.06M | -29.01% |
| Dec 30, 2024 | 77.56M | -3.01% |
| Dec 29, 2023 | 79.96M | -37.33% |
| Dec 30, 2022 | 127.59M | -37.20% |
| Dec 30, 2021 | 203.18M | 13.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evonik Industries AG | 9.98B |
| Brenntag SE | 9.15B |
| Fuchs SE | 5.49B |
| Wacker Chemie AG | 4.38B |
| Verbio SE | 1.72B |
| AlzChem Group AG | 1.65B |
| LANXESS Aktiengesellschaft | 1.05B |
| Uzin Utz SE | 321.83M |